Alirocumab: Difference between revisions
Sergekorjian (talk | contribs) No edit summary |
Sergekorjian (talk | contribs) (Undo revision 1040125 by Sergekorjian (talk)) |
||
| Line 2: | Line 2: | ||
[[File:Pharmacologic-interventions-for-PCSK9.jpg|250px|thumb|right|Pharmacologic interventions for PCSK9 <font size="1">''Adapted from Journal of the American College of Cardiology, 62(16): 1401-1408''<ref name="Urban-2013">{{Cite journal | last1 = Urban | first1 = D. | last2 = Pöss | first2 = J. | last3 = Böhm | first3 = M. | last4 = Laufs | first4 = U. | title = Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. | journal = J Am Coll Cardiol | volume = 62 | issue = 16 | pages = 1401-8 | month = Oct | year = 2013 | doi = 10.1016/j.jacc.2013.07.056 | PMID = 23973703 }}</ref></font>]] | [[File:Pharmacologic-interventions-for-PCSK9.jpg|250px|thumb|right|Pharmacologic interventions for PCSK9 <font size="1">''Adapted from Journal of the American College of Cardiology, 62(16): 1401-1408''<ref name="Urban-2013">{{Cite journal | last1 = Urban | first1 = D. | last2 = Pöss | first2 = J. | last3 = Böhm | first3 = M. | last4 = Laufs | first4 = U. | title = Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. | journal = J Am Coll Cardiol | volume = 62 | issue = 16 | pages = 1401-8 | month = Oct | year = 2013 | doi = 10.1016/j.jacc.2013.07.056 | PMID = 23973703 }}</ref></font>]] | ||
'''For a review of all PCSK9 inhibitors please click [[PCSK9|here]]''' | '''For a review of all PCSK9 inhibitors please click [[PCSK9|here]]''' | ||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Revision as of 16:42, 10 November 2014
For a review of all PCSK9 inhibitors please click here
|
WikiDoc Resources for Alirocumab |
|
Articles |
|---|
|
Most recent articles on Alirocumab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Alirocumab at Clinical Trials.gov Clinical Trials on Alirocumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Alirocumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Alirocumab Discussion groups on Alirocumab Patient Handouts on Alirocumab Directions to Hospitals Treating Alirocumab Risk calculators and risk factors for Alirocumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Alirocumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]